Table 4 Percent malignancy of individual Bethesda scores after repeat USFNA, as compared with initial USFNA
From: The role of repeat fine needle aspiration in the management of indeterminate thyroid nodules
p-USFNA | r-USFNA | Number of cases (%) | Malignant final pathology, n (%) |
|---|---|---|---|
B3 | B2 | 6 (7.4) | 0 (0.0) |
(n = 81) | B3/B4 | 61 (75.3) | 33 (54.01) |
B5/B6 | 14 (17.3) | 14 (100.0) | |
B4 | B2 | 0 (0) | 0 (NA) |
(n = 15) | B3/B4 | 12 (80) | 7 (58.33) |
B5/B6 | 3 (20) | 3 (100.0) |